NCT01825811 - Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions

Degenerative Arthritis

Interventions

BIOLOGICAL

TissueGene-C (Low dose)

TissueGene-C at 1.0 x 10\^6 cells mixed with fibrin-glue

BIOLOGICAL

TissueGene-C (High dose)

TissueGene-C at 3.0 x 10\^6 cells mixed with fibrin-glue

Trial Locations (6)

Kyungpook National University Hospital, Daegu

Inha University Hospital, Incheon

Seoul National University Hospital, Seoul

Samsung Medical Center, Seoul

Asan Medical Center, Seoul

Ewha Womans University Mokdong Hospital, Seoul